Bio-Techne (TECH) Total Non-Current Liabilities (2014 - 2026)

Bio-Techne (TECH) recorded quarterly Total Non-Current Liabilities of $443.6 million in Q1 2026, down 9.21% quarter-over-quarter from $488.6 million in Q4 2025, and down 27.34% on a YoY basis from $610.6 million in Q1 2025.

Bio-Techne (TECH) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Bio-Techne's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $443.6 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 27.34% year-over-year to $443.6 million; the TTM figure through Mar 2026 stood at $443.6 million (down 27.34% YoY), while the FY2025 annual figure was $612.0 million, down 1.59% from the prior year.
  • Total Non-Current Liabilities was $443.6 million for Q1 2026 at Bio-Techne, down from $488.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $749.8 million in Q4 2023 to a low of $443.6 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $606.2 million across 5 years, with a median of $588.1 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities soared 41.67% in 2023, then dropped 27.34% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $529.3 million in 2022, then soared by 41.67% to $749.8 million in 2023, then slipped by 22.57% to $580.6 million in 2024, then retreated by 15.84% to $488.6 million in 2025, then decreased by 9.21% to $443.6 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $443.6 million (Q1 2026), $488.6 million (Q4 2025), and $536.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 443.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 443.63 Mn
Dec 31, 2025 488.63 Mn
Sep 30, 2025 536.52 Mn
Jun 30, 2025 611.98 Mn
Mar 31, 2025 610.58 Mn
Dec 31, 2024 580.60 Mn
Sep 30, 2024 577.58 Mn
Jun 30, 2024 621.86 Mn
Mar 31, 2024 695.24 Mn
Dec 31, 2023 749.83 Mn
Sep 30, 2023 748.22 Mn
Jun 30, 2023 661.26 Mn
Mar 31, 2023 699.04 Mn
Dec 31, 2022 529.30 Mn
Sep 30, 2022 588.07 Mn
Jun 30, 2022 581.56 Mn
Mar 31, 2022 581.77 Mn
Dec 31, 2021 590.57 Mn
Sep 30, 2021 605.63 Mn
Jun 30, 2021 673.42 Mn